1-(4-fluorobenzoyl)-4-(3-benzyl-1,2,4-thiadiazol-5-yl)-2-methylpiperazine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 1-(4-fluorobenzoyl)-4-(3-benzyl-1,2,4-thiadiazol-5-yl)-2-methylpiperazine
• 英文别名: [4-(3-Benzyl-1,2,4-thiadiazol-5-yl)-2-methylpiperazin-1-yl]-(4-fluorophenyl)methanone
• 化学式: C₂₁H₂₁FN₄OS
• 分子量: 396.488
• InChiKey: UGLUEAQVSOOKEN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  77.6
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES
  申请人：NV Remynd

  公开号：EP1981504A2

  公开（公告）日：2008-10-22
• THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
  申请人：GRIFFIOEN Gerard

  公开号：US20090054410A1

  公开（公告）日：2009-02-26

  This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
• THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES
  申请人：Griffioen Gerard

  公开号：US20100144709A1

  公开（公告）日：2010-06-10

  The invention provides novel 1,2,4-thiadiazole derivatives useful for preventing or treating an α-synucleopathy such as Parkinson's disease, as well as pharmaceutical compositions including them as biologically active ingredients, and methods for manufacturing them.
• US7960556B2
  申请人：——

  公开号：US7960556B2

  公开（公告）日：2011-06-14
• US8541406B2
  申请人：——

  公开号：US8541406B2

  公开（公告）日：2013-09-24